INTRODUCTION
Vertebrate neural crest cells are often used to study the process of cell fate specification because they differentiate into a multitude of cell types. The generally held view is that neural crest cells are pluripotent when they emigrate from the neural tube, and differentiate according to molecular cues in the environment into which they migrate (reviewed by Erickson and Reedy, 1998) . Evidence supporting this notion includes heterotopic transplantation studies, in vivo lineage analysis, and clonal analysis done in tissue culture. However, a recent study by Henion and Weston (1997) challenges this notion. They discovered that almost half of the neural crest cells that detach from the trunk neural tube during the first 6 h of culture are already lineage-restricted. Moreover, they found that the first neural crest cells to emigrate are neuronal and glial precursors. Our laboratory discovered that cells with melanogenic potential only begin to migrate after 12 h . These two studies support the unconventional notion that trunk neural crest lineages are established largely at the time they leave the neural tube. Moreover, these lineages segregate temporally, suggesting that different signaling pathways may be responsible for their specification. We asked what signaling events in the trunk-level neural tube establish the neuronal, glial, and melanocyte lineages in the avian embryo.
In the zebrafish, where various neural crest lineages are also spatially segregated (Schilling and Kimmel, 1994) , Dorsky and colleagues (1998) showed that the Wnt signaling pathway specifies the melanocyte lineage. In particular, they discovered that Wnt-1/Wnt-3a is expressed in the dorsal neural tube adjacent to the premigratory neural crest that fate mapping predicts will be pigment cells. When the Wnt signaling pathway is inhibited by expressing a domi-nant negative form of Wnt-1, neural cells differentiate at the expense of pigment cells. Conversely, when the Wnt pathway is activated in individual premigratory neural crest cells fated to be neurons, these crest cells now differentiate into pigment cells. Although avian neural crest lineages are not known to be spatially segregated, they are separated temporally during migration, and we predicted that Wnt signaling might also be important in chick neural crest cell specification. Moreover, one of our labs has recently shown that an inhibitor of the Wnt signaling pathway, cfrzb-1, is expressed in the dorsal neural tube at the time that neuroblasts and glioblasts are migrating, as well as in those neural crest cells that will become neurons and glial cells , but expression appears to be extinguished in melanoblasts (see also Duprez et al., 1999; Ladher et al., 2000) . Because Frzb-1 has been shown to bind and inhibit Wnt-1 (Leyns et al., 1997; Lin et al., 1997; Wang et al., 1997) , it seemed plausible that Wnt signaling is correlated with the timing of melanoblast specification and migration. Conversely, previous tissue culture studies demonstrated that BMP signaling increases the number of neurons that differentiate from quail neural crest cultures (Varley et al., 1995 (Varley et al., , 1998 Varley and Maxwell, 1996) , suggesting that BMP and Wnt signaling might have opposite and competing functions.
We show by in situ hybridization that Wnt-1, are expressed in the dorsal neural tube of stage 13 chick embryos when neural crest cell lineages are being specified. In addition, comparison of the expression patterns of cFoxD3, a marker that distinguishes melanoblasts from nonmelanoblasts (Kos et al., 2001) , and cfrzb-1 reveals that both genes are expressed posteriorly at the time of neuron and glial cell migration, but that neither is expressed anteriorly during emigration of the melanogenic lineage. These expression patterns suggest the possibility that a gradient of Wnt activity in the neural tube of developing chick embryos correlates with melanoblast specification and migration. We show directly that Wnt-3a-conditioned medium results in a dramatic increase in pigment cells in quail neural crest cultures, while significantly decreasing the number of neurons and glial cells. Conversely, purified BMP-4 reduces the number of pigment cells while increasing the numbers of neurons and glial cells. Neither factor stimulates proliferation of a particular subpopulation of the neural crest after they detach from the neural tube, suggesting that Wnt-3a specifies melanocytes at the expense of neurons and glial lineages, and that Wnt and BMP signaling are antagonistic.
MATERIALS AND METHODS

Whole-Mount in Situ Hybridization
Digoxigenin-labeled antisense probes for Wnt-1, Wnt-3a (a gift from Dr. Andy McMahon), and cfrzb-1 were made by transcribing EcoRI-linearized cDNA with T7 RNA polymerase, probe for Wnt-4 (from Andy McMahon) was made by transcribing EcoRI-linearized cDNA with SP6 RNA polymerase, and probe for BMP-4 (a gift from Dr. Paul Sharpe) was made by transcribing HindIII-linearized cDNA with T7 RNA polymerase. In situ hybridization was carried out essentially as described by Baranski et al. (2000) with slight modifications. Chicken embryos (California Golden Eggs, Sacramento; Petaluma Farms, Petaluma) were collected in cold phosphate-buffered saline (PBS), and extraembryonic tissues were removed. Embryos were fixed in 4% paraformaldehyde in PBS and dehydrated in a graded series of PBS-MeOH ending with 100% MeOH. Embryos were rehydrated and bleached with 6% hydrogen peroxide and treated with 10 g/ml proteinase K for 6 -30 min, depending on the embryonic stages. The reaction was quenched by the addition of 2 mg/ml glycine. Embryos were postfixed in 4% paraformaldehyde and 0.2% glutaraldehyde. Hybridization was done at 70°C in hybridization buffer (50% formamide, 2ϫ SSC, 50 g/ml tRNA, 1% SDS, 5% heparin) with probes (10 l probe/ml of hybrization solution). Embryos were washed three times for 1 h at 65°C in washing buffer containing 50% formamide, 5ϫ SSC, and 1% SDS and then an additional three washes in washing buffer containing 50% formamide, 2ϫ SSC, and 1% SDS. Prior to antibody binding, embryos were blocked in MABT (100 mM Maleic acid, 150 mM NaCl, pH 7.5, with Tris base, 0.1% Tween 20) with 2% Boehringer Mannheim blocking reagent and 10% sheep serum (Gibco). Anti-digoxigenin Fab fragments conjugated to alkaline phosphatase (Boehringer Mannheim) were absorbed in 2 ml MABT containing 2% Boehringer Mannheim blocking reagent and 1% sheep serum. The antibodies were then diluted 1:2000. After antibody binding, embryos were washed all day in MABT with a final wash that extended overnight at 4°C. Embryos were stained at room temperature with BM purple (Boehringer Mannheim), and then washed in PBT (PBS containing 0.1% Tween 20) and postfixed with 4% paraformaldehyde and 0.2% glutaraldehyde in PBS. Embryos were embedded in PBS containing 15% sucrose and 7.5% gelatin and then frozen in liquid nitrogen. Sections (30 -45 m) were cut in a Leica cryostat.
Quail Neural Crest Cultures
Fertilized Japanese quail eggs (Coturnix coturnix japonica) from the Avian Sciences Department (University of California-Davis) were incubated in a humidified 37°C incubator until they reached stage 13-15 (Hamburger and Hamilton, 1951) . Neural tubes at somite level V to X (between the fifth from the last-formed somite to the tenth from the last-formed somite) were dissected from embryos and separated from surrounding tissues including ectoderm, somite, and notochord after a brief digestion in Pancreatin (Gibco). Cleaned neural tubes were transferred to 24-well culture dishes (Nunc) and maintained in Ham's F-12 (Gibco) medium supplemented with 10% fetal bovine serum (FBS; Gibco), 3% 10-day chick embryo extract, and 100 units/ml penicillin/ streptomycin (Gibco). The medium was change every 48 h. Neural crest cultures were treated with Wnt-3a-conditioned medium (Wnt-3a-CM; Shibamoto et al., 1998) or BMP-4 (gift of Dr. Vicki Rosen, The Genetics Institute).
Several different subpopulations of neural crest cells were generated. Cultures that are primarily neuroblasts and glioblasts were obtained by removing the neural tube 6 -10 h after explantation . Alternatively, clusters of neural crest cells form on the neural tube after 36-48 h, which will differentiate into virtually all melanocytes (Loring et al., 1981) .
To determine relative percentage of melanocytes, neural crest cells were detached from the substratum with Pancreatin, the
FIG. 1.
Comparison of the expression patterns of cFoxD3, in stage 13 chicken embryos. Whole-mount in situ hybridization was used to detect expression of cfrzb-1 
Immunocytochemistry
Neural crest cultures were grown on coverslips specially treated for culture (Fisher) and fixed with 4% paraformaldehyde. All antibodies were diluted in a buffer containing 0.5 M NaCl, 0.01 M phosphate buffer, pH 7.5, 0.1% sodium azide, and 0.2% Triton X-100. A neuron-specific monoclonal antibody, 16A11 (Molecular Probes), recognizes the Elav family members (Marusich et al., 1994) . Glial cells were detected using the 7B3 monoclonal antibody (Henion et al., 2000 ; kind gift from Dr. J. A. Weston, University of Oregon). After blocking with 3% BSA, neural crest cells were incubated with either 20 g/ml 16A11 or 40 g/ml 7B3 overnight at 4°C in combination with 50 g/ml Hoechst dye (no. 33258; Sigma) to reveal nuclei. All antibodies were detected with Cy2-or Cy3-conjugated secondary antibodies (Jackson Laboratory; 1:500 dilution). Immunolabeled cells were viewed with a Leitz Dialux 20 fluorescence microscope, and images of five fields from each coverslip (two coverslips per experiment) were captured for counting total number of cells and immunolabeled cells.
BrdU Labeling
BrdU incorporation was measured by following the manufacturer's protocol (Boehringer Mannheim). Briefly, neural crest cells were grown on coverslips and incubated in BrdU-labeling medium for 1 h at 37°C. After washing, cells were fixed in 70% ethanol containing 50 mM glycine for 1 h and washed three times with PBS. Following incubation with anti-BrdU primary antibody for 30 min at 37°C, cells were washed and incubated with rhodamine-, Cy2-, or Cy3-conjugated secondary antibody (1:500 dilution) for 30 min at 37°C.
RT-PCR
cDNAs were made directly from cultured neural crest cells by using a Cells-to-cDNA kit (Ambion). Lysis buffer was added to neural crest cultures and incubated for 5 min at 75°C. DNase I was added to cell lysates and incubated for 30 min at 37°C followed by incubation for 5 min at 75°C to inactivate the DNase I activity. First-strand cDNA synthesis was primed with random decamers or oligo(dT) using MMLV-reverse transcriptase. Primers (Operon) were designed for cfrzb-1 (5Ј-CCGATTTCCCAATGGATTCTAA-3Ј, 5Ј-CTCTTCATTGGCACTGAGTGGT3Ј), and for GAPDH (5ЈGATGGGTGTCAACCATGAGAAA-3Ј, 5Ј-ATCAAAGGTG-GAAGAATGGCTG-3Ј). Amplification of cDNA was carried out in a Minicycler (MJ Research) through 35 PCR cycles consisting of denaturation at 94°C for 1 min, annealing at 51°C for 1 min, and extension at 72°C for 1 min. Final amounts of reagents in the reaction were 1 g/ml each primer, 10 mM dNTPs and 1.5 mM MgCl 2 in a final volume of 50 l. Following PCR, reaction products were analyzed on 2% agarose gels.
RESULTS
Expression Patterns of Wnt-1, -3a, and -4, cfrzb-1, and BMP-4
Our hypothesis is that the Wnt signaling pathway stimulates melanogenesis and inhibits neurogenesis/gliogenesis, whereas the BMP-4 signaling pathway stimulates neurogenesis/gliogenesis and inhibits melanogenesis. We first determined whether Wnt-1, -3a, -4, and BMP-4 expression patterns correlate with the timing of melanoblast migration from the neural tube. Previous studies from our lab and others (Henion and Weston, 1997) show that the first neural crest cells to leave the neural tube do not have melanogenic potential, and about 50% of these early migrating neural crest cells are already lineage-restricted as either neuronal or glial cells. Twelve hours after migration has begun, a few neural crest cells with melanogenic potential detach from the neural tube. By 24 h, the majority of emigrating neural crest cells is lineage-restricted as melanoblasts. Because neural crest emigration in the chicken trunk occurs in an anterior-toposterior wave, the emigrating neural crest cells at the level of the last-formed somites are largely fate-restricted as neurons or glial cells, whereas, in the same embryo, neural crest cells at a more anterior axial level are at a more advanced stage of migration and are melanoblasts. We have identified a winged-helix transcription factor, cFoxD3, that is expressed in all trunk neural crest cells except melanoblasts (Kos et al., 2001) . Therefore, we have compared the expression patterns of cFoxD3 with the expression patterns of several Wnts, the Wnt inhibitor cfrzb-1, and BMP-4.
FIG. 2.
cfrzb-1 is expressed in early outgrowths but not in differentiated melanocytes. RT-PCR analysis of cfrzb-1 was performed on RNA from 5-day cultures of 8-h outgrowths, 1-, 3-, and 5-day clusters. GAPDH was used as an internal standard for PCR amplification. PCR products were run on a 2% agarose gel. cfrzb-1 is expressed in early outgrowths, which are primarily neuroblasts and glioblasts, and is gradually reduced until day 5, when expression is no longer detected.
Our hypothesis predicted that Wnts would not be expressed in neural crest cells or in the dorsal neural tube during their early stages of migration, but would be expressed as melanoblasts began to migrate. However, a careful comparison of Wnts and cFoxD3 expression in the dorsal neural tube revealed that Wnts are expressed beginning at the earliest stages of neural crest migration and continue until melanoblast migration is complete (Fig. 1) . Interestingly, an inhibitor of Wnt, cfrzb-1, is coexpressed in the dorsal neural tube and in the earliest migrating neural crest cells . cfrzb-1 expression is extinguished about the time that melanoblasts begin to migrate, as assessed by the loss of cFoxD3 expression. This pattern suggests that Wnts are not actively signaling in the neurogenic and gliogenic neural crest, because the Wntinhibitor, cfrzb-1, is expressed in these early migratory neural crest (Fig. 1) . To confirm the expression of cfrzb-1 in nonmelanogenic neural crest cells, we did an RT-PCR analysis of neural crest cultures (early outgrowths vs. melanoblasts vs. melanocytes). cfrzb-1 transcripts are abundant in early outgrowths, which are primarily neuroblasts and glioblasts, and considerably reduced in melanoblasts (Fig.  2) . Differentiated melanocytes (5-day clusters) no longer express cfrzb-1. No difference in amplification of an internal control, GAPDH, was observed in any of the cDNA samples.
Conversely, we predicted that BMP-4 stimulates neuroand gliogenesis and inhibits melanogenesis. Consistent with this, BMP-4 is expressed in the dorsal neural tube throughout the time when neural and glial precursors are emigrating and is expressed at somewhat lower levels when melanoblasts begin their migration (Fig. 1C) . These latter results suggest that BMP signaling is correlated with the migration of neuroblasts and glioblasts.
Effect of Wnt-3a on Melanogenesis in Vitro
To determine whether Wnt-3a stimulates melanogenesis, we cultured quail neural tubes in Wnt-3a-CM. After 48 h, the medium was replaced with the standard F-12 medium and the neural tube remained throughout the culture period. Neural crest cells that emigrated from the neural tubes in the presence of Wnt-3a-CM showed a significant increase in melanogenesis compared to control CM-treated neural crest cells (Fig. 3) . By day 8 of culture, more than 84% of the outgrowth population were pigmented cells, whereas only 52% of neural crest cells in control medium had differentiated into melanocytes. This increase in melanogenesis could be due to selective proliferation of melanoblast precursors, to an instructive effect of Wnts on pigment cell differentiation, or to both. To investigate this further, we exposed neural crest cells to Wnt-3a for periods of 6, 12, 24,
FIG. 3.
There is a significant increase in melanogenesis in the presence of Wnt-3a-CM. Neural tubes from somite-level V to X were explanted and cultured for 8 days in the presence of Wnt-3a-or control-CM. The number of pigment cells in the neural crest cultures was counted beginning on day 4. The number of individual cultures (2 neural tubes/well) counted is indicated in parenthesis. *** indicates significant difference from the control.
or 48 h beginning at the time of neural tube plating, and assessed melanogenesis after 8 days (Fig. 4) . There was a dramatic increase in melanogenesis, whether the cultures were exposed constantly to Wnt-3a for 48 h, or exposed only briefly for 6 h. However, there was no effect on melanogenesis when neural crest cells were exposed to Wnt-3a beginning 48 h after culture. These data suggest that Wnt-3a acts early, possibly at the time when lineages are being specified.
Our initial studies were done with a mixed population of neural crest precursors. We wanted to determine directly whether Wnt-3a could cause melanocytes to differentiate from neural crest cells that usually do not display melanogenic potential. From previous studies, we know that very few of the neural crest cells that migrate during the first 6 -12 h in culture have melanogenic potential . We therefore treated 10-h early outgrowths with Wnt-3a to see whether nonmelanogenic neural crest cells would differentiate into pigment cells. Trunk neural crest cells were allowed to migrate in vitro from isolated neural tubes for 10 h, in the presence of either Wnt-3a-CM or control CM. The neural tubes were then removed, and the outgrowths were treated with Wnt-3a-CM or control CM, respectively, for an additional 38 h (total of 48 h from time of neural tube plating). There was a dramatic increase in melanogenesis in these early outgrowths compared to control cultures (Fig. 5) . Control CM-treated cultures contained only 14% pigment cells, whereas the Wnt-3a-CM-treated cultures contained 41% pigment cells. These results are consistent with Wnt-3a-inducing melanogenesis. Although   FIG. 4 . Neural crest cultures were exposed to Wnt-3a or control CM for 6, 12, 24, or 48 h, and after 48 h of culture. Neural crest cells were counted on day 8 of culture. Bright field observation (A) and cell counts (B) reveal many more melanocytes present in 6-, 12-, 24-, and 48-h cultures compared to control cultures. However, there is no significant difference in melanogenesis when cultures were treated with Wnt-3a beginning at 48 h after culturing. The number of individual cultures (2 neural tubes/well) counted is indicated in parenthesis. *** indicates significant difference from the control.
it is formally possible that Wnt-3a is selectively causing the proliferation of the few fate-restricted melanoblasts in the 10-h outgrowths, we view this as unlikely because we saw no significant difference in BrdU incorporation in Wnt-3a-vs. control-CM-treated cultures when assessed on day 1 (control 56%, Wnt-3a 44%) and day 3 (control 60%, Wnt-3a 63%) of culture.
If Wnt-3a causes pigment cells to differentiate from neurogenic and gliogenic precursors, then we would expect to see a concomitant decrease in the number of neurons and glial cells in these cultures. We therefore immunolabeled cultures derived from 10-h outgrowths (neural tubes removed after 10 h) with neuron-(16A11) and glial-(7B3) specific markers. 16A11-and 7B3-positive cells were counted in 10 fields for each experiment (total of 3 experiments). Wnt-3a treatment produced a relative decrease in the number of neuronal and glial cells when assayed on day 3. In control cultures, 40% of the total cell population were 16A11-positive, but only 12% of the Wnt-3a-treated population were 16A11-positive (Fig. 5) . Wnt-3a also resulted in a decrease in the number of 7B3-positive cells. In control cultures, 51% of the cells were 7B3-positive, in contrast to 13% 7B3-positive cells in Wnt-3a-treated cultures on day 3. Our data are compatible with the conclusion that Wnt-3a treatment increases the number of pigment cells at the expense of neuronal and glial cells.
To remove any possible influence of the neural tube, and to do our experiments with a known and constant number of cells, we repeated our studies using secondary cultures. Trunk neural crest cells were allowed to migrate in vitro from neural tubes for 16 h in the presence of Wnt-3a. After 16 h, neural crest cells were detached, resuspended, and replated (500 cells/well) in the presence of Wnt-3a-CM or control CM for another 32 h. Forty-eight hours after primary culture, the Wnt-3a-CM or control CM was replaced with the standard F-12 medium, and cells were cultured for another 3 days (total 5 days of culture from initial neural tube plating). Wnt-3a-CM-treated neural crest cells showed a significant increase in melanogenesis compared to control CM-treated neural crest cells. Control cultures contained only 7% pigment cells, whereas Wnt-3a-treated cultures contained 49% pigmented cells (Fig. 6) . However, there was no significant difference in the total cell number per well after 4 days of secondary cultures when treated with Wnt-
FIG. 5.
Wnt-3a produces a significant increase in melanogenesis in 10-h early outgrowths and a concomitant decrease in the number of neuronal and glial cells. Neural crest cells from somite level V to X were allowed to migrate from the neural tube for 10 h in the presence of Wnt-3a or control CM and then neural tubes were removed. Ten-hour outgrowths were treated with fresh Wnt-3a or control CM, respectively, for another 38 h, and the percentage pigment cells determined on day 5 of culture. The number of individual cultures counted is indicated in parentheses. The number of neurons (16A11-positive) and glial cells (7B3-positive) was determined in day-3 cultures by counting five fields in each of two cultures in three different experiments (30 fields total) *** indicates significant difference from the control.
3a-CM or control CM (control 5000 cells/well; Wnt-3a 6458 cells/well), further supporting our conclusion that Wnt-3a was not stimulating selective proliferation of the melanogenic precursors. We immunolabeled these secondary cultures with neuron-(16A11) and glial-(7B3) specific markers. Wnt-3a treatment resulted in a relative decrease in the number of neuronal and glial cells (Fig. 6) . In control cultures, 20% of the total cell population were 16A11-positive, but only 8% of the Wnt-3a-treated population were 16A11-positive. Wnt-3a also induced a decrease in the number of 7B3-positive cells. In control cultures, 75% of the cells were 7B3-positive whereas, in Wnt-3a-treated secondary cultures, 25% were 7B3-positive.
Effect of BMP-4 on Melanogenesis in Vitro
To investigate whether BMP-4 suppresses melanogenesis in vitro, we treated neural crest cultures in which neural tubes remained for the entire culture period with 100 ng/ml of BMP-4 and determined when and how many pigment cells differentiated after 3, 4, or 5 days of culture (Fig. 7) . BMP-4 treatment caused a dramatic decrease in melanogen-FIG. 6. Wnt-3a induces a significant increase in the number of pigment cells and reduces the number of glial cells in secondary cultures. Neural tubes from somite-level V to X were cultured and neural crest cells were allowed to migrate in vitro for 16 h in the presence or absence of Wnt-3a. Outgrowths were then detached, replated (500 cells/well), exposed to Wnt-3a for a total of 48 h, and counted on day 4 of subculturing. Wnt-3a induces a significant increase in the number of pigment cells. The number of individual cultures counted is indicated in parentheses. Neurons and glial cells were identified using 16A11 and 7B3 antibodies, respectively. Hoechst staining was used to visualize all nuclei. For each experiment, five fields were selected from one well of neural crest cells grown on the coverslip, and, in each field, the total number of cells and percentage of cells labeled with 16A11 or 7B3 were determined. Two wells were analyzed from each experiment and the experiment was repeated three times. The total number of fields counted is indicated in parentheses. *** indicates significant difference from the control. esis, even though pigment cells appear earlier in BMP-4-treated neural crest cultures than in control cultures. By day 5 of culture, 5% of the population in BMP-4-treated cultures were pigmented cells, whereas 51% of the cell population were pigmented in control cultures. We further analyzed the effect of varying BMP-4 concentrations, ranging from 1 ng/ml to 100 ng/ml, after 5 days of treatment (Fig. 8A) . The effect of a high concentration (100 ng/ml) of BMP-4 was dramatic. There was also a significant decrease in melanogenesis with 10 ng/ml or 50 ng/ml of BMP-4 assessed at day 5. However, there was no statistical difference in melanogenesis between 1 ng/ml BMP-4-containing medium and control medium. To assess when BMP-4 was acting during differentiation, neural crest cell cultures were treated with 100 ng/ml of BMP-4 for 6, 12, 24, and 48 h (Fig.  8B) . Melanogenesis was significantly decreased after only a 6-h exposure to 100 ng/ml of BMP-4. In contrast, addition of BMP-4 after 2 days of culture resulted in no significant change in melanogenesis. Our data indicate that BMP-4 must be present during the initial appearance of the neural crest (before the first 48 h after migration) in order to suppress melanogenesis.
BrdU incorporation showed that the rate of DNA synthesis did not significantly change in the presence of BMP-4. We repeated these studies using secondary cultures to eliminate any influences from the neural tube and to determine in another way whether BMP-4 was stimulating proliferation of neuronal and glial precursors. Trunk neural crest cells were allowed to migrate in vitro from isolated neural tubes for 16 h in the presence of 100 ng/ml of BMP-4. Neural crest cells were then detached, resuspended, and replated at a concentration of 500 cells/well in the presence of BMP-4. Control cultures contained 10% pigment cells. However, no pigmented cells were observed in the presence of BMP-4 (Fig. 9) . There was no significant difference in the total cell number in the control and BMP-4-treated wells even after 4 days of treatment (control 4073 cells/well; BMP-4 3707 cells/well).
Immunolabeling at day 4 of secondary culture (total 5 days in culture) showed that BMP-4-treated secondary neural crest cultures contained 55% 16A11-positive cells, in contrast to only 29% 16A11-positive cells in control cultures. Similarly, immunolabeling with the 7B3 antibody showed that BMP-4 treatment increased the number of glial cells. A total of 62% of the cells treated with BMP-4 were 7B3-positive cells, whereas 47% were 7B3-positive in control cultures (Fig. 9) .
DISCUSSION
Recent studies in the chick show that a surprising number of neural crest derivatives are specified prior to or shortly after separation from the neural epithelium (Weston, 1991; Artinger and Bronner-Fraser, 1992; Henion and Weston, 1997; Reedy et al., 1998) . The aim of this study was to identify signaling pathways that are involved in the determination of neural crest fate while the cells are still resident in the neural tube. In situ hybridization reveals that various members of the Wnt family are expressed in the dorsal neural tube throughout the time of neural crest cell migration, but that the Wnt inhibitor cfrzb-1 is present primarily during the emigration of neurons and glial cells, suggesting that Wnt activity may stimulate melanogenesis and repress neural and glial cell differentiation. Conversely, BMP-4 is expressed in the neural tube while the neural and glial cell precursors are emigrating, and, in our preparations, appears to be reduced during the early stages of melanoblast migration, consistent with the possibility that BMPs induce neuron and glial cell differentiation. Our tissue culture studies show directly that Wnt-3a stimulates melanogenesis, whereas BMP-4 represses melanogenesis. Neither signaling pathway significantly affects proliferation of cultured neural crest cells, suggesting that these two competing signaling pathways specify some neural crest lineages at the expense of others.
Wnts Stimulate Melanogenesis
In zebrafish, different neural crest cell lineages are spatially segregated in the epithelium prior to their migration (Schilling and Kimmel, 1994) . The melanoblasts are located closest to the neural epithelium, where Wnt-1/3a is expressed, suggesting that Wnt signaling regulates melanogenesis. Dorksy et al., (1998) showed directly, by inhibiting or stimulating the Wnt signaling pathway in individual premigratory neural crest cells, that Wnt signaling specifies the melanocyte lineage at the expense of glial and neuronal lineages. Avian neural crest lineages are not spatially segregated, but they are temporally separated. We and others have shown that the first neural crest lineages to escape from the trunk neural tube are neurons and glial cells and the later migrators are melanoblasts (Henion and Weston, 1997; Reedy et al., 1998) . Thus, we predicted that the Wnt signaling pathway might be a conserved mechanism directing melanogenesis, based on the zebrafish study, and that Wnt expression would be expected to be coincident with the timing of emigration of melanoblasts. Additional support for Wnt regulation of melanogenesis is the observation that mice lacking Wnt-1 and Wnt-3a are almost completely devoid of pigment cells, although they are partially depleted of other neural crest derivatives as well (Ikeya et al., 1997) , whereas overexpression of Wnt-1 in murine neural crest cells results in the expansion in the number of melanocytes (Dunn et al., 2000) .
Our experiments provide evidence that Wnt signaling stimulates melanogenesis in avian neural crest cells grown in culture. When Wnt-3a-CM is added to neural crest cell cultures, there is a significant increase in melanogenesis. This increase in the number of pigment cells appears to be at the expense of other neural crest lineages and not to selective proliferation of the melanoblast lineage. Specifically, Wnt-3a does not affect proliferation of neural crest cells that have already separated from the neural tube based on the BrdU incorporation studies. Also, when neural crest cultures are subcultured after 16 h and replated at known densities, there is no significant difference in the total number of neural crest cells in the Wnt-3a-and controltreated wells 4 days later. Moreover, when we treat 10-h outgrowths, which contain very few neural crest cells with melanogenic potential, with Wnt-3a-CM, we see an enormous increase in the number of pigment cells, much more than could be accounted for by a selective proliferation of the few melanoblasts that are usually found in the 10-h outgrowths. Thus, our data are consistent with the results of Dorksy et al. (1998) , which showed directly that zebrafish glial and neuronal lineages will differentiate into pigment cells when the Wnt signaling pathway is activated, and with Dunn et al. (2000) , who showed that overexpression of Wnt-1 in the murine neural crest produces an increase in the number of melanocytes.
The recent generation of Wnt-3a-CM has made it possible for us to pursue explant studies that have not been previously tractable. Although we would ultimately prefer to use purified Wnt-3a protein in these studies, we feel that the use of conditioned medium is justified for several reasons. First, we have demonstrated by Western blot that Wnt3a-CM does indeed contain Wnt-3a protein, whereas the control conditioned medium does not (Shibamoto et al., 1998) . Second, the Wnt-3a-CM is capable of inducing a
FIG. 7. BMP-4 suppresses melanogenesis in vitro.
Neural tubes from somite level V to X were cultured for 5 days in the presence of 100 ng/ml of BMP-4. Neural crest cultures were counted on days 3, 4, and 5 to determine percentage of melanocytes. The number of individual cultures (2 neural tubes/well) counted is indicated in parentheses. *** indicates significant difference from the control. There was a slight decrease in the percentage of melanocytes from day 4 to day 5 in BMP-4-treated cultures, although this was not a significant difference.
well-established response to Wnt signaling, namely the accumulation of cytosolic ␤-catenin (data not shown) in cultured L cells. And lastly, the concentration of Wnt3a-CM required to induce the accumulation of ␤-catenin in L cell assays is consistent with the amounts used in the studies reported here.
FIG. 8.
Neural crest cultures were treated with BMP-4 in a dose-dependent (A) and time-dependent (B) manner. Neural crest cultures were exposed to BMP-4 and percentage of melanocytes assessed on day 5 of culture. (A) Bright field observations and cell counts demonstrate a decrease in melanogenesis with 10, 50, and 100 ng/ml of BMP-4 treatment, but not with 1 ng/ml of BMP-4 treatment. (B) Cell counting shows a significant decrease in the number of melanocytes present in cultures treated for a total of 6, 12, 24, and 48 h compared to control cultures. However, there is no significant difference in melanogenesis when cultures were treated with BMP-4 beginning 48 h after plating. The number of individual cultures (2 neural tubes/well) counted is indicated in parentheses. *** indicates significant difference from the control.
FIG. 9.
BMP-4 causes a decrease in the number of pigment cells and an increase in the number of neurons and glial cells. Trunk neural tubes from somite level V to X were cultured and neural crest cells were allowed to migrate in vitro for 16 h in the presence or absence of BMP-4. Outgrowths were then detached and replated at a density of 500 cells/well in the presence or absence of BMP-4. Percentage of melanocytes was determined after 4 days of subculture by counting in a hemacytometer. Total number of cultures counted is indicated in parentheses. Neurons and glial cells were identified by immunolabeling using 16A11 and 7B3 antibodies, respectively, after 4 days of subculture. Hoechst staining was done to visualize all nuclei. Total number of fields counted is indicated in parentheses. *** indicates significant difference from the control.
The finding that Wnt-3a did not stimulate proliferation of melanoblasts was somewhat surprising, because Wnts have documented proliferative effects on cells in the neural tube. In particular, transgenic mice in which the hox-B4 promoter is used to drive Wnt-1 expression throughout the neural tube show a vast overgrowth of the neural tube (Dickinson et al., 1994) . Moreover, double knockouts of Wnt-1 and Wnt-3a in the mouse have demonstrated that they are functionally redundant (Ikeya et al., 1997) , suggesting that Wnt-3a should also have proliferative effects on the neural crest cells in our cultures. However, other studies in Xenopus (Saint-Jeannet et al., 1997; LaBonne and BronnerFraser, 1998; Chang and Hemmati-Brivanlou, 1998) suggest that the Wnts play a role in the induction of the neural crest from the neural epithelium. Our studies focused on the time when neural crest cells are detaching from the neural tube, rather than on the earlier stage of induction. Thus, the "proliferative" response seen in some studies might really be an induction of neural crest cells at the expense of the neural epithelial lineages. Consistent with this possibility, we find that an increased number of neural crest cells emigrate from the neural tube, if we expose the neural plate to the Wnt-3a-CM (unpublished data). Alternatively, there may be differences in the cellular response between in vivo expression of Wnt-1 and ectopic application of Wnt-3a in culture. Experiments are currently underway to perturb Wnt signaling in vivo at different times during embryogenesis.
How might the Wnt signaling pathway be stimulating melanogenesis? While our study was in progress, several reports were published showing that Wnts could directly induce the expression of MITF (Takeda et al., 2000; Dorsky et al., 2000) , which is a transcription factor that in turn regulates the expression of a number of melanocyte-specific enzymes, such as TRP-1 and tyrosinase. We have also noted that Wnt-3a-treated cultures express elevated levels of MITF (unpublished results), which is not surprising because these cultures contain many more pigment cells. The complete downstream effects of the Wnt signaling pathway in neural crest cells still remain unknown.
The BMP Signaling Pathway Represses Melanogenesis
Although our data indicate that Wnt signaling is important in directing melanogenesis, it is unlikely that a single signaling pathway is controlling lineage segregation of the neural crest. In fact, there are numerous examples of competing signaling gradients that control lineage switching. Especially noteworthy are the many examples of BMPs antagonizing Wnt signaling in dorsoventral patterning (see discussion below). Although the effect of BMPs on stimulating neurogenesis in avian neural crest cultures has been well documented (Varley et al., 1995 (Varley et al., , 1998 Varley and Maxwell, 1996; Reissmann et al., 1996) , there has been little evidence that BMPs repress melanogenesis, especially in premigratory crest. In fact, it is generally believed that BMPs act relatively late during neural crest cell migration and simulate adrenergic differentiation once the neural crest cells reach the dorsal aorta (Reissmann et al., 1996) .
The results of our culture studies suggest that BMP signaling may be cooperating with Wnt signaling in the lineage segregation of the neural crest. Specifically, they show that BMPs stimulate neuronal and glial cell differentiation and repress melanogenesis. Because BMP-4 does not affect proliferation of neural crest cells that have already detached from the neural tube, based on BrdU incorporation studies and direct cell counts of cells in secondary cultures, we believe that the most parsimonious conclusion is that BMPs can produce a lineage switch from melanoblasts to neuroblasts/glioblasts.
Like Wnt signaling, it appears that BMP signaling can control various aspects of neural crest development, including induction of the neural crest (Liem et al., 1995; Selleck and Bronner-Fraser, 1996) , regulation of the epithelial/ mesenchymal transformation that allows neural crest cells to separate from the neural tube (Delannet and Duband, 1992; Sela-Donenfeld and Kalcheim, 1999) , and the relatively later differentiation of the adrenergic phenotype (Varley and Maxwell, 1996; Reissmann et al., 1996; Varley et al., 1998) . Because we see significant effects of BMP-4 on melanogenesis, even when applied for only the first 6 h of culture, we suggest that BMP signaling can act at yet another time in conjunction with Wnt signaling to control lineage segregation as well. A current focus of our research is to perturb signaling in vivo at precise time points during development to confirm the role of BMPs and Wnts at multiple stages during embryogenesis.
How Might These Signaling Pathways Act Together?
The existence of opposing gradients of Wnt and BMP activity in the neural tube is key to our hypothesis. Although it was the expression of cfrzb-1 transcripts that initially suggested to us the possibility that Wnt activity might be attenuated in the posterior neural tube, it should be noted that multiple Wnts, Frizzleds, and Wnt inhibitors, including cfrzb-1, sfrp-1, sfrp-2, and dkk-3, are expressed in the neural tube (Duprez et al., 1999; Monaghan et al., 1999; Baranski et al., 2000; Terry et al., 2000; Ladher et al., 2000; Esteve et al., 2000) . Until we know the levels of expression of these proteins and their binding affinities, it will be impossible to say with certainty that a gradient of Wnt activity exists in the neural tube. Likewise, we and others have recently observed that BMP-2 can replicate the activities of BMP-4 reported in this paper, suggesting redundancy amongst BMPs expressed in the neural tube. Although the expression pattern of noggin in the neural tube is not consistent with the generation of a BMP-4 gradient in which BMP activity is attenuated rostrally (our unpublished data and Sela-Donenfeld and Kalcheim, 1999) , the upregulation of noggin in the medial somite adjacent to the dorsal neural tube (e.g., Marcelle et al., 1997; Sela-Donenfeld and Kalcheim, 1999) just prior to the time that melanoblasts are emigrating is consistent with such a gradient. Again, as we do not know the levels of all BMPs, BMP receptors, and BMP inhibitory proteins expressed in the neural tube or their relative binding affinities, we cannot establish definitively the presence of a gradient of BMP activity.
Nevertheless, our results are compatible with conclusions drawn from the zebrafish, where Wnt signaling stimulates melanogenesis and BMP signaling represses melanogenesis. Interestingly, BMPs and Wnts have opposing effects in the specification of somite cell lineages as well. Whereas Wnts are known to promote myogenesis (Stern et al., 1995; Mü nsterberg et al., 1995; Capdevila et al., 1998; Ridgeway et al., 2000) and repress chondrogenesis (Rudnicki and Brown, 1997; Stott et al., 1999; Kawakami et al., 1999) , BMP-4 is reported to repress myogenesis (Reshef et al., 1998; Ridgeway et al., 2000) and promote chondrogenesis (Monsoro-Burq et al., 1996) . In addition, Wnts and BMP-4 have opposing effects in patterning the medial and lateral compartments of the somites, where Wnt-1 promotes the expression of medial genes (Marcelle et al., 1997) and BMP-4 promotes the expression of lateral genes (Hirsinger et al., 1997) . The ability of Wnt-1 to induce the expression of noggin, a BMP-4 inhibitor, provides one clue as to how the opposing activities of these two pathways might be coordinated outside the cell (Hirsinger et al., 1997) . How these opposing activities may intersect intracellularly is less clear.
Although Wnt-3a and BMP-4 play a role in neural crest cell lineage specification, these are undoubtedly not the only signals acting in the specification process. An important fact to note is that all of our tissue culture studies were performed in the presence of fetal calf serum and embryo extract. Thus, we cannot rule out the possibility that factors that are synergistic with Wnt-3a and/or BMP-4 are present in our cultures. Numerous studies have revealed roles for components of the extracellular matrix (Sieber-Blum et al., 1981; Loring et al., 1982; Maxwell and Forbes, 1988; Rogers et al., 1990) , as well as other signaling molecules (Vogel and Weston, 1990; Sieber-Blum, 1991; Kalcheim et al., 1992; Henion and Weston, 1994; Shah et al., 1994; Rockwood and Maxwell, 1996; Sieber-Blum, 1998) . One of the challenges for the future will be to understand how these cues are integrated and coordinately regulated with time to pattern neural crest cells lineages in the trunk.
